Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Chubb
McKesson
QuintilesIMS
Medtronic
Accenture

Generated: July 17, 2019

DrugPatentWatch Database Preview

Patent: 9,018,352

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,018,352
Title:Peptide compositions and therapeutic uses thereof
Abstract: Compounds comprising R-G-Cysteic Acid (i.e., R-G-NH--CH(CH.sub.2--SO.sub.3H)COOH or Arg-Gly-NH--CH(CH.sub.2--SO.sub.3H)COOH) and derivatives thereof, including pharmaceutically acceptable salts, hydrates, stereoisomers, multimers, cyclic forms, linear forms, drug-conjugates, pro-drugs and their derivatives. Also disclosed are methods for making and using such compounds including methods for inhibiting cellular adhesion to RGD binding sites or delivering other diagnostic or therapeutic agents to RGD binding sites in human or animal subjects.
Inventor(s): Mackel; Michael J. (Portland, OR), Park; John (Santa Ana, CA)
Assignee: Allegro Pharmaceuticals, Inc. (San Juan Capistrano, CA)
Application Number:12/943,900
Patent Claims:see list of patent claims

Details for Patent 9,018,352

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Sign Up Allegro Pharmaceuticals, Inc. (San Juan Capistrano, CA) ➤ Sign Up RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Sign Up Allegro Pharmaceuticals, Inc. (San Juan Capistrano, CA) ➤ Sign Up RX search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up Allegro Pharmaceuticals, Inc. (San Juan Capistrano, CA) ➤ Sign Up RX Orphan search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Allegro Pharmaceuticals, Inc. (San Juan Capistrano, CA) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,018,352

Country Patent Number Publication Date
South Africa 201204209 Aug 28, 2013
South Africa 201308325 May 27, 2015
World Intellectual Property Organization (WIPO) 2011060104 May 19, 2011
World Intellectual Property Organization (WIPO) 2011060104 Nov 17, 2011
World Intellectual Property Organization (WIPO) 2012154894 May 08, 2014
World Intellectual Property Organization (WIPO) 2012154894 Nov 15, 2012
United States of America 2011182989 Jul 28, 2011
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
QuintilesIMS
Daiichi Sankyo
Express Scripts
Mallinckrodt
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.